Learn More
Medchemexpress LLC L-lysine, N6-[4-(4-iodophenyl)-1-oxobutyl]-, 1,1-dimethylethyl ester | 2703051-80-1 | 98.1% | 474.38 | C20H31IN2O3 | 10 MG

Supplier: Medchemexpress LLC HY15812210MG
A lysine-based pharmacokinetic (PK) modifier supplied as a small-mass tert-butyl ester for use in the synthesis of PSMA-targeting ligands. It is designed to improve pharmacokinetic properties such as plasma residence time and to reduce off-target uptake, making it useful for targeted imaging and radionuclide therapy research.
- Improves plasma residence time by enhancing albumin binding.
- Reduces salivary gland uptake to help minimize off-target accumulation.
- Suitable for incorporation into PSMA-targeting ligand synthesis workflows.
- High purity appropriate for research use (98.1%).
- Supplied as a tert-butyl ester for convenient synthetic handling.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.